CVS Sep 2024 82.500 put

OPR - OPR Delayed price. Currency in USD

Add to watchlist

27.15

0.00

(0.00%)

As of 03:39PM EDT. Market open.

Loading interactive chart…

Fortune
Top CVS medical officer ties shocking lack of ‘health literacy’ for 90 million Americans to crisis of ‘mistrust’
“They’re unable to gather and understand information and apply it to improve their health,” Dr. Michelle Gourdine said at Fortune’s Brainstorm Health conference.
Zacks
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
PR Newswire
CVS Health to present at the Bernstein 40th Annual Strategic Decisions Conference
CVS Health® (NYSE: CVS) today announced that President and CEO Karen S. Lynch and Executive Vice President and Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the Bernstein 40th Annual Strategic Decisions Conference on May 29, 2024, at approximately 10:00 am ET.